Log in

NASDAQ:TTPHTetraphase Pharmaceuticals Earnings Date, Estimates & History

$2.38
-0.05 (-2.06 %)
(As of 07/14/2020 04:00 PM ET)
Add
Compare
Today's Range
$2.34
Now: $2.38▼
$2.47
50-Day Range
$2.16
MA: $2.45▼
$2.77
52-Week Range
$0.56
Now: $2.38▼
$9.15
Volume135,200 shs
Average Volume987,849 shs
Market Capitalization$17.29 million
P/E RatioN/A
Dividend YieldN/A
Beta2.33

Earnings

Tetraphase Pharmaceuticals (NASDAQ:TTPH) Earnings Information

Tetraphase Pharmaceuticals last released its earnings results on May 7th, 2020. The biopharmaceutical company reported ($1.31) earnings per share for the quarter, beating the consensus estimate of ($1.63) by $0.32. The business had revenue of $1.76 million for the quarter, compared to the consensus estimate of $2.45 million. Tetraphase Pharmaceuticals has generated ($22.85) earnings per share over the last year. Tetraphase Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 13th, 2020 based off prior year's report dates.

Tetraphase Pharmaceuticals Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Tetraphase Pharmaceuticals (NASDAQ:TTPH) Earnings Estimates

2020 EPS Consensus Estimate: ($1.68)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20201($0.42)($0.42)($0.42)
Q2 20201($0.42)($0.42)($0.42)
Q3 20201($0.41)($0.41)($0.41)
Q4 20201($0.43)($0.43)($0.43)

Tetraphase Pharmaceuticals (NASDAQ TTPH) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
8/13/2020
(Estimated)		       
5/7/2020Q1 2020($1.63)($1.31)($1.31)$2.45 million$1.76 millionN/A
3/12/202012/31/2019($5.68)($2.75)($2.75)$2.05 million$1.69 millionN/A
11/12/2019Q3($6.27)($6.00)($6.00)$1.55 million$3.34 millionTranscript
8/8/2019Q2 2019($7.60)($8.40)($0.42)$2.13 million$1.07 millionN/A
5/8/20193/31/2019($7.80)($7.20)($0.36)$1.93 million$1.27 millionN/A
3/14/201912/31/2018($8.00)($8.00)($0.40)$2.23 million$4.28 millionTranscript
11/8/20189/30/2018($7.00)($7.40)($0.37)$2.09 million$1.15 millionN/A
8/2/2018Q2 2018($7.20)($3.60)($0.18)$2.23 million$11.58 millionN/A
5/3/2018Q1 2018($9.20)($8.40)($0.42)$1.88 million$1.89 millionN/A
3/8/2018Q4 2017($12.80)($9.20)($0.46)$2.26 million$2.53 millionN/A
11/2/2017Q3 2017($12.60)($12.60)($0.63)$1.59 million$4.10 millionN/A
8/2/2017Q2 2017($15.20)($16.60)($0.83)$1.54 million$1.59 millionN/A
5/4/2017Q1 2017($12.20)($15.80)($0.79)$1.46 million$1.48 millionN/A
3/8/2017Q4 2016($12.20)($0.61)$1.28 million$1.09 millionListen
11/3/2016Q3 2016($9.80)($11.60)($0.58)$1.58 million$0.90 millionN/A
8/4/2016Q2 2016($9.00)($9.40)($0.47)$2.05 million$1.20 millionN/A
5/4/2016Q1 2016($8.80)($9.20)($0.46)$2.20 million$2.00 millionN/A
2/23/2016Q4 2015($9.80)($10.00)($0.50)$3.23 million$2.47 millionListen
11/2/2015Q3 2015($13.20)($9.80)($0.49)$3.20 million$2.90 millionN/A
8/5/2015Q2 2015($12.60)($14.40)($0.72)$2.73 million$3.30 millionN/A
5/6/2015Q1 2015($13.20)($13.20)($0.66)$2.90 million$3.00 millionN/A
3/5/2015Q4 2014($10.80)($13.80)($0.69)$2.74 million$3.07 millionN/A
11/10/2014Q3 2014($12.80)($11.00)($0.55)$2.86 million$2.29 millionN/A
8/12/2014Q2 2014($10.80)($14.20)($0.71)$2.79 million$1.30 millionTranscript
5/12/2014Q1 2014($8.60)($10.60)($0.53)$2.97 million$2.50 millionListen
3/6/2014Q4 2013($9.20)($9.80)($0.49)$2.24 million$1.90 millionN/A
11/14/2013Q3 2013($7.80)($9.80)($0.49)$2.43 million$2.20 millionN/A
8/12/2013Q2 2013($3.60)($5.20)($0.26)$2.41 million$3.72 millionN/A
5/13/2013Q1 2013($6.40)($5.80)($0.29)$2.49 million$2.70 millionTranscript
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 7/15/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.